Brief Title
Hemophilia Mobile App Usability Pilot
Official Title
Bayer/HITLAB - Hemophilia Mobile App Usability Pilot
Brief Summary
The purpose of this study is to evaluate the utility and user experience of a smart phone app for people with medical conditions, used in conjunction with an ActiGraph wearable device and a connected scale.
Detailed Description
HITLAB will conduct a segmented rapid user acceptance study ("rapid UX study") of a smart phone app and an actigraphy device with a connected scale. During the first segment, of one month's duration, subjects will use the app, actigraphy device, and scale. Next, over an interphase period of up to 6 weeks, subjects will only use the app. During this time, the app will be modified based on data collected during the first segment. Finally, during the second period, also of one month's duration, subjects will use the modified app, actigraphy device, and scale.
Study Type
Interventional
Primary Outcome
Usage of the SureSource Engage application as assessed by ActiLife software
Condition
Hemophilia
Intervention
SureSource Engage application
Study Arms / Comparison Groups
Experimental
Description: Multiple device intervention SureSource Engage mobile application ActiGraph Link weight scale
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Device
Estimated Enrollment
20
Start Date
May 22, 2017
Completion Date
May 11, 2018
Primary Completion Date
May 11, 2018
Eligibility Criteria
Inclusion Criteria: 1. You own an iPhone or a Samsung (S5 or higher) smartphone 2. Your age is between 18 and 63 years 3. You reside in the New York metropolitan area 4. You are able to read, write, and speak English 5. You have participated in a concluded clinical trial in the past two years Exclusion Criteria: 1. You do not own an iPhone or a Samsung (S5 or higher) smartphone 2. Your age is not between 18 and 63 years 3. You do not reside in the New York metropolitan area 4. You are not able to read, write, and speak English 5. You have not participated in a concluded clinical trial in the past two years
Gender
All
Ages
18 Years - 63 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Contacts
Stan Kachnowski, PhD, MPA, ,
Location Countries
United States
Location Countries
United States
Administrative Informations
NCT ID
NCT03168685
Organization ID
Pro00021564
Responsible Party
Sponsor
Study Sponsor
Healthcare Innovation Technology Lab
Collaborators
Bayer
Study Sponsor
Stan Kachnowski, PhD, MPA, Principal Investigator, Healthcare Innovation Technology Lab
Verification Date
April 2018